» Articles » PMID: 38842646

Association Between Inflammatory Factors and Melanoma: a Bidirectional Mendelian Randomization Study

Overview
Specialties Oncology
Public Health
Date 2024 Jun 6
PMID 38842646
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study performed a bidirectional Mendelian randomization (MR) analysis to elucidate the causal relationships of C-reactive protein and 41 inflammatory regulators with melanoma, including data from UK Biobank, Cardiovascular Risk in Young Finns Study, and Cohorts for Inflammation Work Group.

Methods: We selected the inverse variance weighting (IVW) to merge the estimated causal effects of multiple SNPs into a weighted average. To evaluate the heterogeneities of IVW, the Cochran Q statistic, and I index were used. What's more, several sensitivity analyses were employed, including IVW, MR-Egger, weighted median, and Mendelian Randomization Pleiotropy RESidual Sum and Outlier (MR-PRESSO).

Results: With SNPs reaching P < 5 × 10, the analyses findings revealed that IL-16 had a significant positively association with genetically risk of melanoma (OR: 1.05; 95% CI: 1.03-1.07; P < 0.001), and high levels of MCP1 (OR: 1.13; 95% CI: 1.03-1.23; P = 0.01) were suggestively associated with melanoma susceptibility. What's more, TNF-β (OR: 1.07; 95% CI: 1.01-1.13; P = 0.02) and IL-8 (OR: 1.08, 95% CI: 1.01-1.16; P = 0.03) were demonstrated a positive association with the risk of melanoma under a less stringent cut-off (P < 5 × 10). Conversely, we found a facilitative effect of melanoma susceptibility on IP-10 and inhibitory effects on IL-6, IL-1b, and GRO-α.

Conclusion: The genetic evidence that we have uncovered indicates a potential association between the levels of specific inflammatory markers (IL-16, IL-8, MCP-1, and TNF-β) and the risk of melanoma. Further research is imperative to translate these findings into clinical applications.

References
1.
Schadendorf D, Fisher D, Garbe C, Gershenwald J, Grob J, Halpern A . Melanoma. Nat Rev Dis Primers. 2016; 1:15003. DOI: 10.1038/nrdp.2015.3. View

2.
Shain A, Yeh I, Kovalyshyn I, Sriharan A, Talevich E, Gagnon A . The Genetic Evolution of Melanoma from Precursor Lesions. N Engl J Med. 2015; 373(20):1926-36. DOI: 10.1056/NEJMoa1502583. View

3.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

4.
Toland A . The influence of sex, age and sunlight exposure on mutational processes in melanoma. Br J Dermatol. 2020; 184(2):197-198. DOI: 10.1111/bjd.19336. View

5.
Renehan A, Tyson M, Egger M, Heller R, Zwahlen M . Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008; 371(9612):569-78. DOI: 10.1016/S0140-6736(08)60269-X. View